The Impact of Government and Public Sector Initiatives on Market Growth
The India Rapid Diagnostics Market is receiving a major boost from a number of proactive government policies and public health initiatives. The government's focus on universal healthcare coverage, coupled with significant investments in strengthening the public health system, is creating a more supportive environment for the diagnostics sector. The Free Diagnostics Service Initiative under the National Health Mission (NHM) is a prime example. This program, which provides essential diagnostic tests free of charge at various levels of public health facilities, has a direct impact on increasing test volumes. For instance, the guidelines specify a list of 9 tests at the Sub-Centre level, 19 at the Primary Health Centre (PHC), and 39 at the Community Health Centre (CHC), which drives the procurement and adoption of rapid diagnostic kits at a massive scale. Furthermore, the government's Production-Linked Incentive (PLI) Scheme is directly fostering the growth of indigenous manufacturing. With an outlay of ₹15,000 crore for the pharmaceuticals and IVD sector, this scheme provides financial support to manufacturers, encouraging local production and reducing the country's reliance on costly imports. This dual-pronged approach—boosting demand through free services and supporting supply through manufacturing incentives—is proving to be a highly effective catalyst for market growth.
Link: Find out how government policies are influencing the market
FAQs
How does the government support the market? The government supports the market through initiatives like the Free Diagnostics Service Initiative and the PLI scheme, which promote both demand and domestic manufacturing.
What is the PLI scheme? The Production-Linked Incentive (PLI) scheme provides financial incentives to local manufacturers to reduce reliance on imports and boost domestic production.